{
  "id": 9537514,
  "title": "US regulators back multi-cancer blood test – but Hong Kong doctors remain cautious",
  "url": "https://urgent.news/2026/09/24/us-regulators-back-multi-cancer-blood-test-but-hong-kong-doctors",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-09-24T10:05:00.000Z",
  "source": {
    "name": "South China Morning Post",
    "slug": "south-china-morning-post",
    "url": "https://www.scmp.com/business/companies/article/3368665/us-regulators-back-multi-cancer-blood-test-hong-kong-doctors-remain-cautious"
  },
  "original_language": "en",
  "account": null,
  "summary": "Efforts to detect multiple cancers through a single blood draw are gathering momentum after US regulators endorsed the technology for the first time, although experts say wider adoption in Hong Kong still faces challenges as doctors remain cautious about its clinical value. In a landmark decision for the emerging field of multi-cancer early detection (MCED) blood tests, a US Food and Drug…",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 2,
    "also_reported_by": [
      {
        "outlet": "South China Morning Post - Hong Kong",
        "title": "Hong Kong reports more than 40% drop in cancer-related death rate over 30 years",
        "url": "https://urgent.news/2026/09/24/hong-kong-reports-more-than-40-drop-in-cancer-related-death-rate-over",
        "published": "2026-09-24T07:34:32.000Z"
      }
    ]
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}